Kohlberg Kravis Roberts & Co’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-88,741
Closed -$884K 256
2022
Q2
$884K Hold
88,741
0.01% 139
2022
Q1
$878K Buy
+88,741
New +$874K 0.01% 149
2021
Q3
Sell
-48,378
Closed -$474K 200
2021
Q2
$474K Buy
+48,378
New +$472K ﹤0.01% 110

Kohlberg Kravis Roberts & Co's ISLE Position: Q3 2022 in Review

Kohlberg Kravis Roberts & Co sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 88,741 shares — an estimated $884K sold.

Kohlberg Kravis Roberts & Co first reported a position in ISLE in Q2 2021 and held it in 3 quarters. The position peaked at $884K in Q2 2022. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

  • Kohlberg Kravis Roberts & Co reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 88,741 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $884K.
  • Kohlberg Kravis Roberts & Co first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q2 2021 and held it in 3 quarters.
  • Kohlberg Kravis Roberts & Co's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $884K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q3 2022, filed 14 Nov 2022.